Several mechanisms have been postulated for the diabetes impact on the TB treatment outcome that includes altered immunological response17,18, increased insulin resistance due to anti-tuberculosis drugs particularly, Rifampicin and impaired immunity due to diabetes itself19. Here, INS is linked to diabetes mellitus.